Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity?
Kayasut
K
K
Le Tourneau
A
A
Rio
B
B
Bost-Bezeaud
F
F
Heuberger
L
L
Diebold
J
J
Audouin
J
J
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D005871:Castleman Disease / Q000188:drug therapy / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D010950:Plasma Cells / Q000473:pathology*; D010954:Plasmacytoma / Q000188:drug therapy / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone